Management of Subcapsular Hematoma
Assessment and Classification
- Subcapsular hematomas are collections of blood between the organ parenchyma and its capsule, most commonly affecting the liver and kidneys 1
- Assessment should include evaluation of hemodynamic status, hematoma size, underlying cause, and presence of active bleeding 1, 2
- For liver subcapsular hematomas, the AAST liver injury scale helps classify severity, with Grade I: Subcapsular hematoma <10% surface area, Grade II: Subcapsular hematoma 10-50% surface area, and Grade III: Subcapsular hematoma >50% surface area or expanding/ruptured 3
Management Approach
Conservative Management
- For hemodynamically stable patients with subcapsular hematomas, non-operative management (NOM) is the standard of care 1, 2
- Conservative management includes serial clinical evaluation and hemoglobin measurement 1, bedside ultrasound for monitoring hematoma size 1, ICU admission for moderate to severe cases for close monitoring 1, correction of coagulopathy if present 2
Indications for Intervention
- Hemodynamic instability despite resuscitation efforts 1, 2
- Expanding hematoma with signs of impending rupture 2
- Evidence of ongoing bleeding 2
- Development of abdominal compartment syndrome 2
- Secondary infection of the hematoma 2
Intervention Options
- Angiography with embolization is a first-line intervention for active bleeding in hemodynamically stable patients 1
- Percutaneous drainage is indicated for symptomatic or infected bilomas/hematomas 2
- Surgical management is reserved for hemodynamically unstable patients with active bleeding not controlled by embolization 1, 2
Organ-Specific Considerations
Liver Subcapsular Hematoma
- Complications include rupture, infection, and biliary complications (bile leak, biloma) 2
- For large subcapsular hematomas without rupture, close monitoring with serial imaging is recommended 1, 2
Follow-up and Monitoring
- Serial imaging (ultrasound or CT) to monitor hematoma resolution 1, 2
- Laboratory monitoring of organ function (liver enzymes, renal function) 2
- Long-term follow-up to assess for delayed complications such as pseudoaneurysm formation 1